Philip Morris Q3 revenue and adj EPS beat on smoke-free products growth

By Reuters News


Overview

  • Tobacco and nicotine products maker's Q3 revenue rose, beating analyst expectations

  • Adjusted EPS for Q3 grew 5.4% to $2.36, beating analyst expectations

  • Reported EPS declined 4.9% due to non-cash equity security adjustment


Outlook

  • Philip Morris sees 2026 adj diluted EPS at $8.29-$8.44, up 9.9%-11.9% vs 2025


Result Drivers

  • SMOKE-FREE GROWTH - Co said smoke-free product volumes rose 2.7% in Q3, with broad-based growth across all categories and markets

  • COMBUSTIBLE PRICING - Co said strong pricing in combustibles segment contributed to net revenue and margin expansion

  • ZYN PORTFOLIO - Co said US net revenues rose 22.7% in Q3, driven by ZYN nicotine pouch shipments and favorable price comparisons against prior year promotions


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$11.44 bln

$11.28 bln (11 Analysts)

Q3 Adjusted EPS

Beat

$2.36

$2.29 (13 Analysts)

Q3 EPS

$2.12


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the tobacco peer group is "buy"

  • Wall Street's median 12-month price target for Philip Morris International Inc. is $210.00, about 5.1% above its October 20 closing price of $199.90

  • The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • Oct 20 - GE Aerospace raises profit outlook as engine repairs defy fuel shock, Boeing costs loom

  • Oct 19 - Global food inflation is expected to intensify as supply shocks pile up


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.